Francesco D. Raimondo
Catania, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real-World Study.
Journal: Hematological oncology
Published: October 18, 2025
Correction: Mancuso et al. Forcing Ahead: Second-Line Treatment Options for Lenalidomide-Refractory Multiple Myeloma. Cancers 2025, 17, 1168.
Journal: Cancers
Published: June 27, 2025
Correction: Sgherza et al. Efficacy and Safety of Isatuximab, Carfilzomib, and Dexamethasone (IsaKd) in Multiple Myeloma Patients at the First Relapse After Autologous Stem Cell Transplantation and Lenalidomide Maintenance: Results from the Multicenter, Real-Life AENEID Study. Pharmaceuticals 2025, 18, 595.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 27, 2025
Outcomes of Patients With Extramedullary Disease in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma From the Pooled LocoMMotion and MoMMent Studies.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 03, 2025
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience.
Journal: Vaccines
Published: November 15, 2024
Impact of minimal residual disease response and of status of disease on survival after blinatumomab in B-cell acute lymphoblastic leukemia: results from a real-life study.
Journal: Annals of hematology
Published: February 25, 2024
Immunological Subsets Characterization in Newly Diagnosed Relapsing-Remitting Multiple Sclerosis.
Journal: Frontiers in immunology
Published: November 20, 2021
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells.
Journal: Biomolecules
Published: March 07, 2020
Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies.
Journal: International journal of molecular sciences
Published: October 10, 2019
High BCR-ABL/GUSIS Levels at Diagnosis of Chronic Phase CML Are Associated with Unfavorable Responses to Standard-Dose Imatinib.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 01, 2017
Rare gastrointestinal lymphomas: The endoscopic investigation.
Journal: World journal of gastrointestinal endoscopy
Published: March 12, 2015
Mistletoes and mutant albino shoots on woody plants as mineral nutrient traps.
Journal: Annals of botany
Published: March 24, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026